Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of hepatocellular carcinoma
IntroductionHepatocellular carcinoma (HCC) constitutes a significant global health burden, and is characterized by limited early detection methods and poor survival rates. Golgi protein 73 (GP73), previously associated with liver-related diseases, has a controversial diagnostic value for HCC. The pr...
Saved in:
| Main Authors: | Qian Wang, Hongxia Cui, Yaping Zhu, Yichun Zhu, Chunyan He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1571761/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combining AFP, PIVKA-II, and GP73 has diagnostic utility for hepatitis B-associated hepatocellular carcinoma and is consistent with liver pathology results
by: Hu Rui, et al.
Published: (2025-04-01) -
The use of biomarkers GP-73 and AFP in the early diagnosis of hepatocarcinoma associated with liver cirrhosis of HCV etiology
by: A. K. Bayjanov, et al.
Published: (2025-06-01) -
Diagnostic Accuracy of Golgi Protein 73 (GP73) for Liver Fibrosis Staging in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Scoping Review and Cohort Study
by: Valentina Pecoraro, et al.
Published: (2025-02-01) -
GP73-dependent regulation of exosome biogenesis promotes colorectal cancer liver metastasis
by: Linfei Huang, et al.
Published: (2025-05-01) -
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
by: Shan Hong, et al.
Published: (2025-01-01)